Effect of Cannabidiol on the Long-Term Toxicity and Lifespan in the Preclinical Model Caenorhabditis elegans

M. Hunter Land,Marton L. Toth,Laura MacNair,Siva A. Vanapalli,Timothy W. Lefever,Erica N. Peters,Marcel O. Bonn-Miller
DOI: https://doi.org/10.1089/can.2020.0103
2021-12-01
Cannabis and Cannabinoid Research
Abstract:<b>Introduction:</b> Despite widespread use of cannabidiol (CBD), no lifelong toxicity study has been published to date. <i>Caenorhabditis elegans</i> is often used in preclinical lifelong toxicity studies, due to an estimated 60-80% of their genes having a human ortholog, and their short lifespan of ∼2-3 weeks. In this study, we examined both acute and long-term exposure studies of CBD at physiologically relevant concentrations. <b>Materials and Methods:</b> Acute toxicity was determined by treating day 1 adults with a wide range of CBD concentrations (0.4 μM to 4 mM) and assessing mortality and motility compared to control animals. Thermotolerance was examined by treating adult animals with CBD (0.4 μM to 4 mM) and exposing them to 37°C for 4 h, and then scoring for the number of alive animals treated with CBD compared to controls. Long-term toxicity was assessed by exposing day 1 adults to 10, 40, and 100 μM CBD until all animals perished. Control animals had no active drug exposure. <b>Results:</b> We report both acute and long-term exposure studies of CBD to adult <i>C. elegans</i> at physiologically relevant concentrations. Acute toxicity results showed that no animal died when exposed to 0.4-4000 μM CBD. The thermotolerance study showed that 40 μM CBD, but not other treatment levels, significantly increased resistance to heat stress by 141% compared to the untreated controls. Notably, whole-life exposure of <i>C. elegans</i> to 10-100 μM CBD revealed a maximum life extension of 18% observed at 40 μM CBD. In addition, motility analysis of the same groups revealed an increase in late-stage life activity by up to 206% compared to controls. <b>Conclusion:</b> These results serve as the only CBD lifelong exposure data in an <i>in vivo</i> model to date. While further research into the lifelong use of CBD should be carried out in mammalian models, the <i>C. elegans</i> model indicates a lack of long-term toxicity at physiologically relevant concentrations.
pharmacology & pharmacy
What problem does this paper attempt to address?